BANDHIGH SIGNALFINANCIAL10-K

Net losses nearly doubled to $12.9M despite 25% revenue growth, primarily driven by significantly increased non-operating expenses that more than offset operational improvements.

The dramatic 98% increase in net losses despite solid revenue growth and improving operating performance suggests BAND is facing substantial non-operating headwinds that are severely impacting profitability. While the company shows positive operational momentum with revenue growth and reduced operating losses, investors should be concerned about the underlying factors driving the widening gap between operating and net performance.

Comparing 2026-02-19 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

BAND demonstrates a mixed financial picture with strong top-line growth of 25% to $204M and meaningful operational improvement as operating losses narrowed 28% to $14.4M, indicating better cost management despite 12% higher R&D spending. However, net losses nearly doubled to $12.9M, suggesting significant non-operating expenses are undermining operational progress. The company strengthened its balance sheet with 28% higher stockholders' equity to $400M and increased cash reserves to $103M, while reducing capital expenditures by 45%, positioning it well financially despite the profitability challenges.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-97.9%
-$6.5M-$12.9M

Net income declined 97.9% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
-44.8%
$22.2M$12.3M

Capex reduced 44.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
+28.4%
-$20.1M-$14.4M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Stockholders Equity
Balance Sheet
+28%
$312.5M$400.0M

Equity base grew 28% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
+25.6%
$81.8M$102.8M

Cash grew 25.6% — improving liquidity position supports investment and shareholder returns.

Revenue
P&L
+25.3%
$163.0M$204.1M

Revenue growing 25.3% — solid top-line momentum, watch margins for quality of growth.

Current Assets
Balance Sheet
+16.6%
$187.8M$219.1M

Current assets grew 16.6% — improving short-term liquidity or inventory/receivables build.

R&D Expense
P&L
+11.7%
$118.6M$132.5M

R&D investment increased 11.7% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-20
ADDED
As of February 13, 2026, 29,428,894 shares of the registrant s Class A common stock and 1,958,028 shares of registrant s Class B common stock were outstanding, respectively.
Risk Factors Summary The following is a summary of the principal risks that could adversely affect our business, results of operations and financial condition.
Risks Related to Our Business Our growth and financial health are subject to a number of economic risks.
Nearly all of our operating cash is held in financial institution accounts that are not FDIC-insured.
We use AI in our business, and challenges in managing it could adversely affect our results of operations.
+7 more — sign up free →
REMOVED
As of February 14, 2025, 26,665,744 shares of the registrant s Class A common stock and 1,958,028 shares of registrant s Class B common stock were outstanding, respectively.
Risks Related to Our Business Our future growth and the success of our expansion plans depend on a number of factors that are beyond our control.
Our growth and financial health are subject to a number of economic risks.
Nearly all of our operating cash is maintained in deposit accounts with various financial institutions and is not insured by the Federal Deposit Insurance Corporation ( FDIC ).
We use AI in our business, and challenges with properly managing its use could adversely affect our results of operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →